# A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis

> **NCT07533955** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Jade Biosciences, Inc.** · enrollment: 36 (estimated)

## Conditions studied

- Rhematoid Arthritis

## Interventions

- **DRUG:** JADE201
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07533955
- **Lead sponsor:** Jade Biosciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2027-10
- **Final completion:** 2028-10
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07533955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07533955, "A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07533955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*